XXXX subtypes: Clinical and psychological features, body mass index and comorbidities.

@entity1 @entity308 @entity239 @entity294 @entity148 @entity2794 @entity354 @entity2210 @entity1142 @entity1744 @entity8352
BACKGROUND: @entity1744 ( @entity8352 ) is classified into subtypes according to bowel habit. OBJECTIVE: To investigate whether there are differences in clinical features, comorbidities, @entity148 , @entity308 and body mass index (BMI) among @entity8352 subtypes. METHODS: The study group included 113 consecutive @entity1 (mean age: 48    11 years; females: 94) with the diagnosis of @entity8352 . All of them answered a structured questionnaire for demographic and clinical data and underwent upper endoscopy. @entity148 and @entity308 were assessed by the Hospital @entity148 and @entity308 scale (HAD). RESULTS: The distribution of subtypes was: @entity8352 - @entity294 ( @entity8352 -D), 46%; @entity1142 ( @entity1142 ), 32%, and mixed @entity8352 ( @entity8352 ), 22%. @entity8352 overlap with @entity354 ( @entity354 ), @entity2210 , @entity2794 and @entity239 occurred in 65.5%, 48.7%, 40.7% and 22.1% of @entity1 , respectively. @entity308 were found in 81.5%. Comparisons among subgroups showed that bloating was significantly associated with @entity8352 compared to @entity8352 -D (odds ratio-OR-5.6). Straining was more likely to be reported by @entity8352 (OR 15.3) and @entity1142 (OR 12.0) compared to @entity8352 -D @entity1 , while urgency was associated with both @entity8352 (OR 19.7) and @entity8352 -D (OR 14.2) compared to @entity1142 . In addition, @entity8352 @entity1 were more likely to present @entity354 than @entity8352 -D (OR 6.7) and higher scores for @entity148 than @entity1142 @entity1 (OR 1.2). BMI values did not differ between @entity8352 -D and @entity1142 . CONCLUSION: @entity8352 is characterized by symptoms frequently reported by both @entity1142 (straining) and @entity8352 -D (urgency), higher levels of @entity148 , and high prevalence of comorbidities. These features should be considered in the clinical management of this subgroup.
